Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 1301 - 1325 of 6046 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▲ Formula
Gangliosides LMSP0601DC07
  • Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262578 1424.875538 C71H128N2O26
Gangliosides LMSP0601DG07
  • GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
  • KDN-GM2(d18:1/24:1(15Z))
44262610 1424.875538 C71H128N2O26
Gangliosides LMSP0601DC05
  • Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262576 1426.891188 C71H130N2O26
Gangliosides LMSP0601DG05
  • GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
  • KDN-GM2(d18:1/24:0)
44262608 1426.891188 C71H130N2O26
Gangliosides LMSP0601CI03
  • GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/20:0)
52931291 1427.850052 C69H125N3O27
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AI03
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44260550 1428.870453 C70H128N2O27
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AC03
  • Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • Lewis a(d18:1/20:0)
44260630 1428.870453 C70H128N2O27
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AD03
  • Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • type I H antigen(d18:1/20:0)
44260638 1428.870453 C70H128N2O27
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AB03
  • Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • Lex-5(d18:1/20:0)
44260982 1428.870453 C70H128N2O27
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AD03
  • Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
  • type II antigen(d18:1/20:0)
44260998 1428.870453 C70H128N2O27
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AV03
  • Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
44261606 1428.870453 C70H128N2O27
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AC01
  • Forssman antigen(d18:1/16:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260180 1429.829317 C68H123N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AD01
  • GalNAcbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Para-Forssman x3b(d18:1/16:0)
44260188 1429.829317 C68H123N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BC01
  • GalNAcbeta1-3(GalNAcbeta1-4)Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260388 1429.829317 C68H123N3O28
Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BD01
  • GlcNAcbeta1-6GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260396 1429.829317 C68H123N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AC01
  • GalNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260500 1429.829317 C68H123N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AE01
  • GlcNAcbeta1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260516 1429.829317 C68H123N3O28
GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AO01
  • GalNAcbeta1-4(Galbeta1-4GlcNAcbeta1-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260596 1429.829317 C68H123N3O28
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AJ01
  • GlcNAcbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260684 1429.829317 C68H123N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AK01
  • GlcNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • nLc5Cer(d18:1/16:0)
44261052 1429.829317 C68H123N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505BN01
  • GalNAcbeta1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • P antigen(d18:1/16:0)
44261284 1429.829317 C68H123N3O28
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505CE01
  • GlcNAcalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261420 1429.829317 C68H123N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AD01
  • Forssman-like iGb4(d18:1/16:0)
  • GalNAcalpha1-3GalNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261860 1429.829317 C68H123N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AO01
  • GalNAcbeta1-3Galalpha1-3(GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261924 1429.829317 C68H123N3O28
Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506BG01
  • GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261676 1429.829317 C68H123N3O28

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024